Parallel Advisors, LLC Quest Diagnostics Inc Transaction History

Parallel Advisors, LLC

  • $4.18 Billion
  • Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 3,352 shares of DGX stock, worth $459,525. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,352
Previous 3,204 4.62%
Holding current value
$459,525
Previous $438,000 4.79%
% of portfolio
0.01%
Previous 0.01%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$137.09 - $137.09 $20,289 - $20,289
148 Added 4.62%
3,352 $459,000
Q2 2024

Aug 08, 2024
SELL
$125.91 - $144.34 $18,131 - $20,784
-144 Reduced 4.3%
3,204 $438,000
Q1 2024

May 06, 2024
SELL
$123.78 - $142.11 $67,707 - $77,734
-547 Reduced 14.04%
3,348 $445,000
Q4 2023

Feb 09, 2024
SELL
$120.62 - $141.12 $24,244 - $28,365
-201 Reduced 4.91%
3,895 $537,000
Q3 2023

May 20, 2024
SELL
$121.86 - $144.92 $20,228 - $24,056
-166 Reduced 3.89%
4,096 $499,000
Q3 2023

Nov 13, 2023
SELL
$121.86 - $144.92 $20,228 - $24,056
-166 Reduced 3.89%
4,096 $499,000
Q2 2023

May 20, 2024
SELL
$130.56 - $146.84 $15,406 - $17,327
-118 Reduced 2.69%
4,262 $599,000
Q2 2023

Aug 04, 2023
SELL
$130.56 - $146.84 $15,406 - $17,327
-118 Reduced 2.69%
4,262 $599,000
Q1 2023

May 20, 2024
BUY
$131.53 - $155.76 $135,738 - $160,744
1,032 Added 30.82%
4,380 $619,000
Q1 2023

Apr 25, 2023
SELL
$131.53 - $155.76 $5,918 - $7,009
-45 Reduced 1.02%
4,380 $619,000
Q4 2022

Feb 03, 2023
BUY
$123.31 - $157.26 $32,923 - $41,988
267 Added 6.42%
4,425 $692,000
Q3 2022

Nov 10, 2022
SELL
$121.77 - $141.1 $6,332 - $7,337
-52 Reduced 1.24%
4,158 $510,000
Q2 2022

Aug 01, 2022
SELL
$127.07 - $145.39 $762 - $872
-6 Reduced 0.14%
4,210 $560,000
Q1 2022

Apr 28, 2022
SELL
$129.09 - $164.35 $70,483 - $89,735
-546 Reduced 11.47%
4,216 $586,000
Q4 2021

Jan 20, 2022
SELL
$140.36 - $173.01 $49,266 - $60,726
-351 Reduced 6.86%
4,762 $824,000
Q3 2021

Nov 02, 2021
BUY
$132.95 - $158.0 $102,637 - $121,976
772 Added 17.78%
5,113 $743,000
Q2 2021

Aug 06, 2021
BUY
$126.66 - $141.48 $8,359 - $9,337
66 Added 1.54%
4,341 $573,000
Q1 2021

Apr 23, 2021
BUY
$114.63 - $133.34 $9,628 - $11,200
84 Added 2.0%
4,275 $549,000
Q4 2020

Feb 02, 2021
SELL
$112.7 - $128.05 $2,479 - $2,817
-22 Reduced 0.52%
4,191 $499,000
Q3 2020

Oct 27, 2020
SELL
$107.05 - $130.01 $33,720 - $40,953
-315 Reduced 6.96%
4,213 $482,000
Q2 2020

Jul 16, 2020
BUY
$73.34 - $122.61 $46,497 - $77,734
634 Added 16.28%
4,528 $516,000
Q1 2020

Apr 27, 2020
BUY
$75.14 - $115.68 $215,877 - $332,348
2,873 Added 281.39%
3,894 $312,000
Q4 2019

Jan 30, 2020
SELL
$100.29 - $107.99 $9,126 - $9,827
-91 Reduced 8.18%
1,021 $109,000
Q3 2019

Nov 01, 2019
BUY
$97.85 - $107.42 $587 - $644
6 Added 0.54%
1,112 $119,000
Q2 2019

Aug 05, 2019
SELL
$85.18 - $101.94 $1,448 - $1,732
-17 Reduced 1.51%
1,106 $113,000
Q1 2019

May 01, 2019
SELL
$80.68 - $89.92 $2,097 - $2,337
-26 Reduced 2.26%
1,123 $101,000
Q4 2018

Feb 05, 2019
BUY
$79.75 - $108.38 $1,276 - $1,734
16 Added 1.41%
1,149 $95,000
Q2 2018

Jul 30, 2018
BUY
$97.35 - $113.14 $194 - $226
2 Added 0.18%
1,133 $124,000
Q1 2018

May 08, 2018
SELL
$96.42 - $107.88 $8,099 - $9,061
-84 Reduced 6.91%
1,131 $113,000
Q4 2017

Feb 13, 2018
BUY
$90.86 - $100.24 $3,452 - $3,809
38 Added 3.23%
1,215 $120,000
Q3 2017

Nov 15, 2017
BUY
$91.96 - $108.35 $108,236 - $127,527
1,177 New
1,177 $108,000
Q3 2017

Nov 14, 2017
SELL
$91.96 - $108.35 $118,720 - $139,879
-1,291 Closed
0 $0
Q2 2017

Aug 07, 2017
BUY
N/A
1,291
1,291 $140,000

Others Institutions Holding DGX

# of Institutions
925
Shares Held
95.1M
Call Options Held
379K
Put Options Held
354K
View Full List

About QUEST DIAGNOSTICS INC

DGX Quotes by TradingView
  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email